We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
- Authors
Nuvoli, Barbara; Antoniani, Barbara; Libener, Roberta; Maconi, Antonio; Sacconi, Andrea; Carosi, Mariantonia; Galati, Rossella
- Abstract
B Representative western blot analyses of COX-2 and CYP19A1 expression in Ist Mes1, Ist Mes2 and MPP89 cells treated with 35 M exemestane (EXE) or 35 M rofecoxib (ROF) or 35 M exemestane and 35 M rofecoxib combination (EXE + ROF) for 24 h. Reference 1 Nuvoli B, Antoniani B, Libener R. Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.
- Subjects
CYCLOOXYGENASE 2; MESOTHELIOMA
- Publication
Journal of Experimental & Clinical Cancer Research (17569966), 2023, p1
- ISSN
1756-9966
- Publication type
Correction Notice
- DOI
10.1186/s13046-022-02539-3